Clinical translation of TLR7/8 agonists for cancer immunotherapyis an active area of research,15 with atleast 10 ongoing clinical trials evaluating their efficacy in a varietyof tumor types, many of which show promising early results (clinicaltrials.gov). The gene discussed is TLR7; the disease is neoplasm.